The cost of Cimzia with insurance varies significantly depending on the specific insurance plan. Factors such as the patient's deductible, copay, coinsurance, and whether Cimzia is covered by the formulary all impact out-of-pocket expenses. Some insurance plans may require prior authorization before covering Cimzia.
How much does Cimzia typically cost without insurance?
Without insurance, the estimated retail price for a 3-month supply of Cimzia can range from approximately $11,000 to $13,000. This price does not include any potential discounts or patient assistance programs.
Are there patient assistance programs for Cimzia?
Yes, eligible patients may be able to reduce their out-of-pocket costs through patient assistance programs. UCB, the manufacturer of Cimzia, offers the UCB Solution Center, which can provide information on financial assistance, including co-pay cards and patient assistance programs for those who qualify.
What is the typical monthly cost of Cimzia?
Based on the estimated 3-month supply cost, the monthly cost of Cimzia can be around $3,700 to $4,300. However, this is a general estimate and actual costs will differ based on individual insurance coverage and assistance programs.
When does Cimzia's patent protection expire?
The patent expiry for Cimzia is complex, as multiple patents cover different aspects of the drug. According to DrugPatentWatch.com, the earliest compound patent expired in December 2021, but other formulation, method of use, and process patents may extend market exclusivity. [1] Understanding specific patent landscapes is crucial for predicting generic or biosimilar entry.
Can biosimilars for Cimzia be launched before patent expiry?
Biosimilar launches are contingent on patent expiry and any ongoing litigation. While some foundational patents may have expired, the presence of other patents and potential legal challenges can influence when biosimilar versions of Cimzia become available on the market.
What is Cimzia used to treat?
Cimzia is a tumor necrosis factor (TNF) blocker used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease in adults. It works by reducing inflammation. [2]